Microsatellite instability and the association with plasma homocysteine and thymidylate synthase in colorectal cancer

被引:13
作者
Jensen, Lars Henrik
Lindebjerg, Jan
Cruger, Dorthe Gylling
Brandslund, Ivan
Jakobsen, Anders
Kolvraa, Steen
Nielsen, Jens Nederby
机构
[1] Vejle Hosp, Dept Oncol, DK-7100 Vejle, Denmark
[2] Univ So Denmark, Danish Colorectal Canc Grp S, DK-7100 Vejle, Denmark
关键词
microsatellite instability; homocysteine; thymidylate synthase; methylation; colorectal cancer;
D O I
10.1080/07357900801970992
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The possible associations between microsatellite instability, homocysteine and thymidylate synthase were investigated in tumors and plasma from 130 patients with colorectal cancer. Other analyses included thymidylate synthase and 5,10-methylene-tetrahydrofolate reductase gene polymorphisms, carcinoembryonic antigen, vitamin B12, and folate. Microsatellite instability of tumors was associated with higher levels of plasma homocysteine (p = 0.008) and higher protein expression of thymidylate synthase (p < 0.001). Supplemental analyses ruled out that the finding could be explained by the other analyzed factors. CEA was not associated with neither homocysteine nor microsatellite instability. The data suggests that there is a more pronounced methyl unit deficiency in microsatellite instable tumors.
引用
收藏
页码:583 / 589
页数:7
相关论文
共 36 条
  • [1] Calascibetta A, 2004, ANTICANCER RES, V24, P3875
  • [2] Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study
    Chen, J
    Kyte, C
    Valcin, M
    Chan, W
    Wetmur, JG
    Selhub, J
    Hunter, DJ
    Ma, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (04) : 617 - 620
  • [3] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
    FROSST, P
    BLOM, HJ
    MILOS, R
    GOYETTE, P
    SHEPPARD, CA
    MATTHEWS, RG
    BOERS, GJH
    DENHEIJER, M
    KLUIJTMANS, LAJ
    VANDENHEUVEL, LP
    ROZEN, R
    [J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
  • [4] Grady WM, 2001, CANCER RES, V61, P900
  • [5] Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
    Herman, JG
    Umar, A
    Polyak, K
    Graff, JR
    Ahuja, N
    Issa, JPJ
    Markowitz, S
    Willson, JKV
    Hamilton, SR
    Kinzler, KW
    Kane, MF
    Kolodner, RD
    Vogelstein, B
    Kunkel, TA
    Baylin, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) : 6870 - 6875
  • [6] A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
    Iacopetta, B
    Grieu, F
    Joseph, D
    Elsaleh, H
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (06) : 827 - 830
  • [7] Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity
    Jakobsen, A
    Nielsen, JN
    Gyldenkerne, N
    Lindeberg, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1365 - 1369
  • [8] Jensen LH, 2006, ANTICANCER RES, V26, P2069
  • [9] Cancer epigenetics comes of age
    Jones, PA
    Laird, PW
    [J]. NATURE GENETICS, 1999, 21 (02) : 163 - 167
  • [10] Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer
    Jover, R.
    Zapater, P.
    Castells, A.
    Llor, X.
    Andreu, M.
    Cubiella, J.
    Pinol, V.
    Xicola, R. M.
    Bujanda, L.
    Rene, J. M.
    Clofent, J.
    Bessa, X.
    D Morillas, J.
    Nicolas-Perez, D.
    Paya, A.
    Alenda, C.
    [J]. GUT, 2006, 55 (06) : 848 - 855